Literature DB >> 19250224

Parkinson's disease and cancer: insights for pathogenesis from epidemiology .

Marco D'Amelio1, Paolo Ragonese, Gabriella Sconzo, Paolo Aridon, Giovanni Savettieri.   

Abstract

Epidemiological evidence suggests a reduced incidence of many common types of cancers in individuals with Parkinson's disease (PD). Parkinson's disease and cancer are two diseases that result from an excessive signaling by one of two forces driving cells to opposite directions. PD results from the excessive death of dopaminergic neurons in the substantia nigra pars compacta (SNc) in the brain, while uncontrolled growth is the key property of cancer. Parkinson's disease is a complex disorder, probably due in most of the cases to the interaction of environment and genes. Many genes responsible for familial forms of PD are supposed to have a supportive role in regulating or maintaining the cell cycle, a fact that allows us to assume their interaction in tumorigenesis. Understanding the nature of these processes may help researchers find new and more efficacious therapeutic approaches for both diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19250224     DOI: 10.1111/j.1749-6632.2008.03681.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

1.  Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.

Authors:  Ilir Agalliu; Roberto A Ortega; Marta San Luciano; Anat Mirelman; Claustre Pont-Sunyer; Kathrin Brockmann; Dolores Vilas; Eduardo Tolosa; Daniela Berg; Bjørg Warø; Amanda Glickman; Deborah Raymond; Rivka Inzelberg; Javier Ruiz-Martinez; Elisabet Mondragon; Eitan Friedman; Sharon Hassin-Baer; Roy N Alcalay; Helen Mejia-Santana; Jan Aasly; Tatiana Foroud; Karen Marder; Nir Giladi; Susan Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2019-07-26       Impact factor: 10.338

2.  Associations between cancer and Parkinson's disease in U.S. elderly adults.

Authors:  D Michal Freedman; Jincao Wu; Honglei Chen; Eric A Engels; Lindsey R Enewold; Neal D Freedman; James J Goedert; Ralph W Kuncl; Mitchell H Gail; Ruth M Pfeiffer
Journal:  Int J Epidemiol       Date:  2016-03-17       Impact factor: 7.196

3.  Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.

Authors:  Qinyong Ye; Wanling Huang; Dongzhu Li; Erwang Si; Juhua Wang; Yingqing Wang; Chun Chen; Xiaochun Chen
Journal:  Mol Neurobiol       Date:  2015-07-04       Impact factor: 5.590

Review 4.  The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers.

Authors:  Rivka Inzelberg; Simon D Israeli-Korn
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

5.  α-Synuclein expression selectively affects tumorigenesis in mice modeling Parkinson's disease.

Authors:  Eitan Israeli; Eugenia Yakunin; Yonaton Zarbiv; Amir Hacohen-Solovich; Haya Kisos; Virginie Loeb; Michal Lichtenstein; Tziona Ben-Gedalya; Ofra Sabag; Eli Pikarsky; Haya Lorberboum-Galski; Ronit Sharon
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

Review 6.  Diametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunology.

Authors:  Bernard J Crespi; Matthew C Go
Journal:  Evol Med Public Health       Date:  2015-09-09

7.  Proliferating cell nuclear antigen binds DNA polymerase-β and mediates 1-methyl-4-phenylpyridinium-induced neuronal death.

Authors:  Zhentao Zhang; Zhaohui Zhang; Hongcai Wang; Guoxin Zhang; Dan Hu; Jing Xiong; Nian Xiong; Tao Wang; Xuebing Cao; Ling Mao
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

8.  PDbase: a database of Parkinson's disease-related genes and genetic variation using substantia nigra ESTs.

Authors:  Jin Ok Yang; Woo-Yeon Kim; So-Young Jeong; Jung-Hwa Oh; Sungwoong Jho; Jong Bhak; Nam-Soon Kim
Journal:  BMC Genomics       Date:  2009-12-03       Impact factor: 3.969

Review 9.  Advances with microRNAs in Parkinson's disease research.

Authors:  Liuqing Ma; Liangming Wei; Fei Wu; Zhenhua Hu; Zhenguo Liu; Weien Yuan
Journal:  Drug Des Devel Ther       Date:  2013-10-01       Impact factor: 4.162

10.  Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons.

Authors:  Hsiao-Yun Lin; Wei-Lan Yeh; Bor-Ren Huang; Chingju Lin; Chih-Ho Lai; Ho Lin; Dah-Yuu Lu
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.